in sera from patients with systemic sclerosis (scleroderma). The authors performed a series of experiments that confirmed that these antibodies recognized and activated native PDGFR on fibroblasts.

Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

With their mouse data in hand, the team turned to humans. They collected blood from healthy people and people with three different autoimmune conditions: dermatomyositis, scleroderma, and lupus. They ...

AliveDx has submitted a 510(k) premarket notification seeking approval from the US Food and Drug Administration (FDA) for its ...